IL6 and COVID-19: Circulating levels of IL-6 have also been used as predictive biomarker to identify severe SARS-CoV-2 pathology [114] and the increased levels of IL-6 were found to correlate with several abnormalities in blood tests observed in patients suffering from COVID-19 [115], as well as in HIV patients developing autoimmune disease [116].